CLOs on the Move


 
Baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
  • Number of Employees: 10K-50K
  • Annual Revenue: > $1 Billion
  • www.baxter.com
  • 1 Baxter Parkway
    Deerfield, IL USA 60015
  • Phone: 800.422.9837

Executives

Name Title Contact Details
Edward Ryan
Sr. Dir, IT, Office of CIO Profile
Annlea Rumfola
EVP, Chief Information Officer Profile
Heather Knight
Chief Operating Officer Profile
Chris Toth
Chief Executive Officer Profile
Carl Jenkins
Associate General Counsel, Legal-Regulatory Profile

Similar Companies

Bone Bank Allografts

Bone Bank Allografts is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BioSig

BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig aims to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP™ System is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP™ System in August 2018. BioSig Technologies, Inc. is a Nasdaq company: NASDAQ:BSGM.

AUSTIN MEDICAL

AUSTIN MEDICAL is a Apopka, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fukuda Denshi

Fukuda Denshi is a Redmond, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Partners Imaging

Partners Imaging is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.